Search

everythinglearnresearchcommunity

for

Search:↓

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Thicker hair grows faster; hair loss patients have slower growth.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

PRP therapy effectively improves hair density and reduces hair loss in androgenetic alopecia.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Some off-label treatments increase hair density, but long-term safety unknown.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

Compound 15a was effective in inhibiting 5α-reductase.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

PRP with microneedling effectively treats hair loss, and dermoscopy helps evaluate results.